Bengaluru: Pfizer Ltd, the Indian unit of US pharmaceutical group Pfizer Inc, on Monday reported a 3.1 per cent rise in fourth-quarter profit, helped by lower raw material expenses. Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 Editorial Prediabetes in India: Sugary Iceberg and Place of Metformin to Mitigate it Prediabetes in India: Navigating the Sugary Crisis with DCGI-Approved Metformin LENS trial a first of its kind large scale trial shows striking 27% reduction in diabetic... The Role of Aspirin in Reducing ASCVD Mortality Among Adults with High Lp(a) Concentrations API- ICP issue practical guidelines for doctors for management of Hypertension in patients with Type... Journal Club  Today The Role of Probiotics in Prenatal Health: Study Sheds Light on Benefits for Moms and Babies Health News Today Health Bulletin 17/ August/ 2024